SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-24-000598
Filing Date
2024-07-23
Accepted
2024-07-23 08:00:38
Documents
15
Period of Report
2024-07-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea020982001-8k_180lifesci.htm   iXBRL 8-K 29355
2 PRESS RELEASE, DATED JULY 23, 2024 ea020982001ex99-1_180lifesci.htm EX-99.1 16663
  Complete submission text file 0001013762-24-000598.txt   272829

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20240722.xsd EX-101.SCH 3799
4 XBRL DEFINITION FILE atnf-20240722_def.xml EX-101.DEF 26637
5 XBRL LABEL FILE atnf-20240722_lab.xml EX-101.LAB 36680
6 XBRL PRESENTATION FILE atnf-20240722_pre.xml EX-101.PRE 25261
17 EXTRACTED XBRL INSTANCE DOCUMENT ea020982001-8k_180lifesci_htm.xml XML 5824
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 241132963
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)